Corporate | 29 March 2004 07:45

Eckert & Ziegler: Clear improvement in net income with sales unchanged

Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– Eckert & Ziegler: Clear improvement in net income with sales unchanged Berlin, March 29, 2004. The annual financial statements, now audited, of Eckert & Ziegler AG (ISIN DE 0005659700), a specialist in medical and industrial radiation technology, show that a notable improvement in its net income has been achieved in 2003 on sales unchanged over the previous year. Earnings per share (ignoring changes to reporting standards) rose in the 2003 financial year by 153% to 0.28 EUR. Cash and cash equivalents, including readily realizable securities, increased by 15% to 9.8 million EUR, despite debt repayment and a share buy-back program. Sales at 29.2 million EUR were affected by the adverse dollar exchange rate and were slightly below the level of the previous year (31.2 million EUR). The equity ratio was maintained at a high level (63%). For the current financial year the Berlin-based group anticipates earnings of 0.40 EUR per share. The detailed annual report is available at http://www.ezag.de . The Executive Board Your contact for inquiries: Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Str. 10, 13125 Berlin, Germany Tel.: +49 (0) 30 / 94 10 84-138 http://www.ezag.de end of message, (c)DGAP 29.03.2004 ——————————————————————————– WKN: 565970; ISIN: DE0005659700; Index: Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover und Stuttgart 290745 Mär 04